(Q50766711)

18 March 2018

title

Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer. (English)

1 reference

18 March 2018

author name string

Yuanting Xiao

1

1 reference

18 March 2018

Sheng Zhang

2

1 reference

18 March 2018

Guofang Hou

3

1 reference

18 March 2018

Xiaobei Zhang

4

1 reference

18 March 2018

Xiaomeng Hao

5

1 reference

18 March 2018

Jin Zhang

6

1 reference

18 March 2018

publication date

5 October 2013

1 reference

18 March 2018

published in

Tumor Biology

1 reference

18 March 2018

volume

35

1 reference

18 March 2018

issue

3

1 reference

18 March 2018

page(s)

2035-2045

1 reference

18 March 2018

https://scigraph.springernature.com/pub.10.1007/s13277-013-1270-5

exact match

0 references

cites work

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Circulating tumor cells (CTCs) in breast cancer: a diagnostic tool for prognosis and molecular analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

The impact of diabetes mellitus on prognosis of early breast cancer in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Hormone responsive human breast cancer in long-term tissue culture: effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Multiple signal pathways in obesity-associated cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Obesity and cancer risk: evidence, mechanisms, and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Obesity and the risk for a hematological malignancy: leukemia, lymphoma, or myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Obesity in cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1270-5

Breast cancer manifested by hematologic disorders

21 January 2018

1 reference

12 December 2020

The insulin and insulin-like growth factor receptor family in neoplasia: an update

1 reference

12 December 2020

Influence of insulin administration on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in intact, oophorectomized, and hypophysectomized rats

1 reference

12 December 2020

[Metformin does not suppress the aromatase expression in breast cancer tissue of patients with concurrent type 2 diabetes]

1 reference

12 December 2020

Promoter-specific effects of metformin on aromatase transcript expression

1 reference

12 December 2020

Type 2 diabetes mellitus and prognosis in early stage breast cancer women

1 reference

12 December 2020

Insulin signaling in health and disease

1 reference

12 December 2020

Epidemiology and prognosis of breast cancer in young women

1 reference

12 December 2020

10.1007/S13277-013-1270-5

Identifiers

DOI

1 reference

18 March 2018

PubMed ID

24096546

1 reference

18 March 2018